• SPX
  • $5,985.38
  • 0.02 %
  • $1.39
  • DJI
  • $43,958.19
  • 0.11 %
  • $47.21
  • N225
  • $38,761.02
  • 0.1 %
  • $39.36
  • FTSE
  • $8,030.33
  • 0.06 %
  • $4.56
  • IXIC
  • $19,230.74
  • -0.26 %
  • -$50.66
Moleculin Biotech, Inc. (MBRX) Ownership

Moleculin Biotech, Inc. (MBRX) Ownership

NASDAQ Currency in USD Disclaimer

Stock Price

$2.50

-$0.14

(-5.12%)

Day's range
$2.5
Day's range
$2.63
Recent Quarter Total Invested

$4.44 M

$3.51 M
Recent Quarter Institutional Ownership Percentage

17.39%

$10.14
Total Invested of Last Quarter

$925,096

Ownership Percentage of Last Quarter

7.25%

Moleculin Biotech, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
ARMISTICE CAPITAL, LLC 02/13/2024 3.21 M $2.75 M   100.00% 10.76%
VANGUARD GROUP INC 03/11/2024 1.08 M $927,177   0.00% 3.62%
GEODE CAPITAL MANAGEMENT, LLC 02/13/2024 246,670 $211,802   0.00% 0.83%
BLACKROCK INC. 02/13/2024 188,924 $162,172   -3.76% 0.63%
RENAISSANCE TECHNOLOGIES LLC 02/13/2024 129,600 $111,000   7.82% 0.43%
STATE STREET CORP 02/14/2024 71,397 $61,287   0.00% 0.24%
CITADEL ADVISORS LLC 02/14/2024 64,652 $55,497   100.00% 0.22%
NORTHERN TRUST CORP 02/13/2024 53,596 $46,007   0.00% 0.18%
ATTICUS WEALTH MANAGEMENT, LLC 01/17/2024 50,001 $42,921   100.00% 0.17%
SCHMIDT P J INVESTMENT MANAGEMENT INC 01/29/2024 29,000 $14,094   0.00% 0.10%
ROYAL BANK OF CANADA 02/14/2024 20,148 $17,000   100.00% 0.07%
JMAC ENTERPRISES LLC 01/26/2024 13,132 $11,273   0.00% 0.04%
SIGMA PLANNING CORP 02/01/2024 12,000 $10,301   -29.41% 0.04%
TOWER RESEARCH CAPITAL LLC (TRC) 02/13/2024 7,201 $6,178   -49.66% 0.02%
MORGAN STANLEY 08/16/2024 6,334 $5,437   0.00% 0.02%
SANDY SPRING BANK 01/26/2024 1,333 $1,145   100.00% 0.00%
ADVISOR GROUP HOLDINGS, INC. 02/12/2024 968 $831   0.00% 0.00%
CVA FAMILY OFFICE, LLC 01/16/2024 500 $429   100.00% 0.00%
NORTH STAR INVESTMENT MANAGEMENT CORP. 01/10/2024 250 $215   0.00% 0.00%
WELLS FARGO & COMPANY/MN 02/09/2024 229 $197   -68.06% 0.00%
BANK OF AMERICA CORP /DE/ 02/14/2024 138 $118   38.00% 0.00%
JPMORGAN CHASE & CO 02/12/2024 52 $45   44.44% 0.00%
NEWEDGE ADVISORS, LLC 02/13/2024 2 $2   100.00% 0.00%
FMR LLC 02/13/2024 0 $0   -100.00% 0.00%
MILLENNIUM MANAGEMENT LLC 02/14/2024 0 $0   -100.00% 0.00%
SIO CAPITAL MANAGEMENT, LLC 02/13/2024 0 $0   -100.00% 0.00%
UBS GROUP AG 02/09/2024 0 $0   -100.00% 0.00%

Moleculin Biotech, Inc.institutional Ownership - Frequently Asked Questions

  • Who are the largest shareholders of MBRX shares?

    During the previous two years, 2 institutional investors and hedge funds held shares of Moleculin Biotech, Inc.. The most heavily invested institutionals were:

    American Portfolios Advisors: 334

    Urban Wealth Management, LLC: 3,019

  • What percentage of Moleculin Biotech, Inc. stock is owned by institutional investors?

    17.39% of Moleculin Biotech, Inc. stock is owned by institutional investors.

  • How much institutional buying is happening at MBRX ?

    Institutional investors have bought a total of 3,353 shares in the last 24 months. This purchase volume represents approximately $8,383 in transactions.

×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.

×

Log In


or

download app using google store Continue with Google download app using apple Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to Stocks.News!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.